# Granata Bio Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/granata-bio

- Industry: Biotechnology
- Headquarters: Duxbury, US
- Website: www.granata.bio/
- Total disclosed funding: $28M
- Latest round: Series A (Dec 19, 2024)
- Investors on record: 6

## About

Founded in 2018 and based in Massachusetts, US, Granata Bio Corporation operates as a biopharmaceutical firm that focuses on identifying and marketing important drugs for the health and infertility of women. In January 2025, the company raised USD 15 million in series A funding from Gedeon Richter, The Cooper Companies, Inc., Amboy Street Ventures, and other unspecified investors.

The company will use the January 2025 funding to advance its existing drug pipeline and explore new assets in reproductive health.

## Funding rounds

- Series A, Dec 19, 2024, $14M — Gedeon Richter, The Cooper Companies, Inc., Amboy Street Ventures
- Series A, Jan 16, 2024, $14M — GV, Gedeon Richter, Alumni Ventures Group, The Cooper Companies, Inc., Amboy Street Ventures, Vibe Biotechnology Inc.

## Investors

- GV (https://capitalatlas.ai/funds/gv) — Series A
- Gedeon Richter — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- The Cooper Companies, Inc. — Series A
- Amboy Street Ventures (https://capitalatlas.ai/funds/amboy-street-ventures) — Series A
- Vibe Biotechnology Inc. — Series A